Assessment of the Cost Burden of Episodic Recurrent Vestibular Vertigo in the US.

ABSTRACT:

Importance

Understanding of the economic burden of recurrent vestibular causes of vertigo and areas contributing to the cost is needed.

Objective

To analyze and identify the factors contributing to the direct medical costs associated with Ménière disease (MD), vestibular migraine (VM), and benign paroxysmal positional vertigo (BPPV).

Design, setting, and participants

This economic evaluation used MarketScan Commercial Database claims data from 2018 to identify the non-Medicare patient population with the diagnoses of MD, VM, or BPPV. Data were analyzed January 1 to December 31, 2018.

Main outcomes and measures

The total direct medical costs associated with MD, VM, and BPPV.

Results

A total of 53 210 patients (mean [SD] age, 47.8 [11.8] years; 67.6% femal

SUBMITTER: Jeong SS 

PROVIDER: S-EPMC9562102 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature